{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:49:55Z","timestamp":1791841795388,"version":"4.3.4"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1097\/olq.0b013e3182215512","type":"journal-article","created":{"date-parts":[[2011,5,27]],"date-time":"2011-05-27T08:06:52Z","timestamp":1306483612000},"page":"949-956","source":"Crossref","is-referenced-by-count":74,"title":["The Impact of Anogenital Warts on Health-Related Quality of Life: A 6-Month Prospective Study"],"prefix":"10.1097","volume":"38","author":[{"given":"M\u00e9lanie","family":"Drolet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Brisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Maunsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo L.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Coutl\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Ferenczy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Ratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Mansi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210213","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.","volume":"199","author":"Garland","year":"2009","journal-title":"J Infect Dis"},{"key":"R2-15-20210213","first-page":"630","article-title":"FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).","volume":"59","year":"2010","journal-title":"Morb Mortal Wkly Rep"},{"key":"R3-15-20210213","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1185\/03007990903136378","article-title":"Assessing incidence and economic burden of genital warts with data from a US commercially insured population.","volume":"25","author":"Hoy","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"R4-15-20210213","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/OLQ.0b013e318198de8c","article-title":"Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in Canada.","volume":"36","author":"Kliewer","year":"2009","journal-title":"Sex Transm Dis"},{"key":"R5-15-20210213","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/OLQ.0b013e3181a74c2c","article-title":"Cost of treatment and QALYs lost due to genital warts: Data for the economic evaluation of HPV vaccines in the United Kingdom.","volume":"36","author":"Woodhall","year":"2009","journal-title":"Sex Transm Dis"},{"key":"R6-15-20210213","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/eurpub\/ckn127","article-title":"Epidemiology and cost of treatment of genital warts in Spain.","volume":"19","author":"Castellsague","year":"2009","journal-title":"Eur J Public Health"},{"key":"R7-15-20210213","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/sti.2008.030999","article-title":"Epidemiology and costs associated with genital warts in Canada.","volume":"85","author":"Marra","year":"2009","journal-title":"Sex Transm Infect"},{"key":"R8-15-20210213","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/522863","article-title":"The burden of genital warts: A study of nearly 70,000 women from the general female population in the 4 Nordic countries.","volume":"196","author":"Kjaer","year":"2007","journal-title":"J Infect Dis"},{"key":"R9-15-20210213","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1258\/095646205774357334","article-title":"The role of illness perceptions: Psychological distress and treatment-seeking delay in patients with genital warts.","volume":"16","author":"Ireland","year":"2005","journal-title":"Int J STD AIDS"},{"key":"R10-15-20210213","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/sti.2007.029512","article-title":"Estimation of the impact of genital warts on health-related quality of life.","volume":"84","author":"Woodhall","year":"2008","journal-title":"Sex Transm Infect"},{"key":"R11-15-20210213","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/OLQ.0b013e318191a55e","article-title":"Patients with genital warts have a decreased quality of life.","volume":"36","author":"Marra","year":"2009","journal-title":"Sex Transm Dis"},{"key":"R12-15-20210213","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/sti.2009.037028","article-title":"The psychosocial burden of human papillomavirus related disease and screening interventions.","volume":"85","author":"Pirotta","year":"2009","journal-title":"Sex Transm Infect"},{"key":"R13-15-20210213","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/sti.2009.039982","article-title":"Loss of quality of life associated with genital warts: Baseline analyses from a prospective study.","volume":"87","author":"Senecal","year":"2011","journal-title":"Sex Transm Infect"},{"key":"R14-15-20210213","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00435221","article-title":"Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire.","volume":"2","author":"Brazier","year":"1993","journal-title":"Qual Life Res"},{"key":"R15-15-20210213","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00005650-200001000-00013","article-title":"Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada.","volume":"38","author":"Johnson","year":"2000","journal-title":"Med Care"},{"key":"R16-15-20210213","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF00439226","article-title":"Health state valuations from the general public using the visual analogue scale.","volume":"5","author":"Gudex","year":"1996","journal-title":"Qual Life Res"},{"key":"R17-15-20210213","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states.","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"key":"R18-15-20210213","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/01.mlr.0000135827.18610.0d","article-title":"The estimation of a preference-based measure of health from the SF-12.","volume":"42","author":"Brazier","year":"2004","journal-title":"Med Care"},{"key":"R19-15-20210213","article-title":"SF Health Outcomes Scoring Software User's Guide.","author":"Saris-Baglama","year":"2004"},{"key":"R20-15-20210213","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.2044-8260.1992.tb00997.x","article-title":"The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI).","volume":"31","author":"Marteau","year":"1992","journal-title":"Br J Clin Psychol"},{"key":"R21-15-20210213","first-page":"265","article-title":"Canadian normative data for the SF-36 health survey.","volume":"163","author":"Hopman","year":"2000","journal-title":"CMAJ"},{"key":"R22-15-20210213","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1471-0528.2007.01609.x","article-title":"A 2-year follow-up study of anxiety and depression in women referred for colposcopy after an abnormal cervical smear.","volume":"115","author":"Hellsten","year":"2008","journal-title":"BJOG"},{"key":"R23-15-20210213","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00449430","article-title":"Swedish population norms for the GHRI, HI and STAI-state.","volume":"2","author":"Forsberg","year":"1993","journal-title":"Qual Life Res"},{"key":"R25-15-20210213","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1185\/03007990903238786","article-title":"Development and psychometric properties of the HPV Impact Profile (HIP) to assess the psychosocial burden of HPV.","volume":"25","author":"Mast","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"R26-15-20210213","doi-asserted-by":"crossref","DOI":"10.1201\/9781420035438","article-title":"Design and Analysis of Quality of Life Studies in Clinical Trials.","author":"Fairclough","year":"2002"},{"key":"R27-15-20210213","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status. Ascertaining the minimal clinically important difference.","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control Clin Trials"},{"key":"R28-15-20210213","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s11136-004-7713-0","article-title":"Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.","volume":"14","author":"Walters","year":"2005","journal-title":"Qual Life Res"},{"key":"R30-15-20210213","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00007435-199709000-00001","article-title":"Delayed presentation to clinics for sexually transmitted diseases by symptomatic patients. A potential contributor to continuing STD morbidity.","volume":"24","author":"Hook","year":"1997","journal-title":"Sex Transm Dis"},{"key":"R31-15-20210213","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0277-9536(83)90246-0","article-title":"Gender roles, illness orientation and use of medical services.","volume":"17","author":"Hibbard","year":"1983","journal-title":"Soc Sci Med"},{"key":"R33-15-20210213","article-title":"Twenty Year Trends (1985\u20132004) in the Incidence and Prevalence of Anogenital Warts in Manitoba.","author":"Kliewer","year":"2008"},{"key":"R34-15-20210213","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/427557","article-title":"Development and duration of human papillomavirus lesions, after initial infection.","volume":"191","author":"Winer","year":"2005","journal-title":"J Infect Dis"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/OLQ.0b013e3182215512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:26:34Z","timestamp":1786044394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007435-201110000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0b013e3182215512","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}